Sarah Talebagha, M.D., Joins Baptist Health Heart & Vascular Care
-
By
-
October 20, 2026
-
4 min
By
October 20, 2026
From gummies to hookworms, trackers to vibrating pills, medicine took some unexpected turns this week.
by Teraya Smith
June 18, 2026
Phase 3 VERIFY results showed a 77% clinical response rate during weeks 20 to 32.
August 31, 2026
Merck reported placebo-adjusted LDL-C reductions of 56% and 59% at week 24 in two phase 3 CORALreef trials supporting the approval.
July 16, 2026